CG:600572 Zhejiang CONBA Pharmaceutical Co.,Ltd

Zhejiang CONBA Pharmaceutical Co., Ltd. is a China-based company engaged in the research, development, production and sale of traditional Chinese medicines, herbal medicines, chemical drugs, bulk drugs and healthcare products. The Company's main products consist of Qianliekang branded tablets and capsules for the treatment of prostatitis; Tianbaoning branded tablets and capsules for the treatment of cardiovascular and cerebrovascular disease; CONBA branded tablets for the treatment of enteritis, as well as Beibei series nutrition liquids for children, among others. The Company distributes its products mainly in domestic markets, with eastern China as its main market.

5.05 CNY
As of 01/17/2022


Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Health Care
Industry:  Drug Manufacturers-General
Index country:  China
Country of incorporation:  China
IPO date:  04/13/2004
Stock exchange:    Shanghai Stock Exchange
Exchange country:   China
Market cap:   13,184,306,176 CNY
Current dividend yield:   2.95%
Sedol:      BP3R8M0

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy